scutellarin has been researched along with Angor Pectoris in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, DD; Zhao, H; Zhao, J; Zhi, YJ | 1 |
| Cheng, D; Gao, S; Li, Y; Liu, E; Wang, C; Zhao, S | 1 |
| Fu, CG; Guo, SY; Liu, SY; Liu, XK; Meng, ZQ; Ni, MW; Wu, JR; Zhou, W; Zhu, YL | 1 |
1 review(s) available for scutellarin and Angor Pectoris
| Article | Year |
|---|---|
[Efficacy and safety of breviscapine injection in treatment of unstable angina pectoris: systematic review and Meta-analysis].
Topics: Angina Pectoris; Angina, Unstable; Female; Flavonoids; Humans; Male; Randomized Controlled Trials as Topic | 2018 |
2 other study(ies) available for scutellarin and Angor Pectoris
| Article | Year |
|---|---|
Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients.
Topics: Angina Pectoris; Flavonoids; Humans; Injections; Publication Bias; Randomized Controlled Trials as Topic; Ultrasonography | 2015 |
Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach.
Topics: Angina Pectoris; Apigenin; Brain Ischemia; Glucuronates; Humans; Ischemic Stroke; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases | 2021 |